|Articles|November 1, 2013
- BioPharm International-11-01-2013
- Volume 26
- Issue 11
BioPharm International, November 2013 Issue (PDF)
Click the title above to open the BioPharm International November 2013 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 12 years ago
Supplier-Change Management for Drug-Product Manufacturersabout 12 years ago
Report from Brazilabout 12 years ago
Risk Aversion and Closed-System Processingabout 12 years ago
The State of the Used-Equipment Marketabout 12 years ago
Challenges in Managing the Cold Chainabout 12 years ago
European Union Introduces GMPs for Excipientsabout 12 years ago
Congress Revises Rules for Drug Compounding and Supply-Chain Securityabout 12 years ago
USP Plans Standards on Good Distribution Practicesabout 12 years ago
New Funding and Approval Pathways Prove PopularNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
2
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
3
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
4
Coya Raises $11.1 Million to Advance Immunomodulatory ALS Program
5
